Treffer 1 - 4 von 4 für Suche 'Allameddine, Allameddine', Suchdauer: 0,46s Treffer weiter einschränken
  1. 1
    Platelet Pathogen Reduction Technology-Should We Stay or Should We Go…?

    Platelet Pathogen Reduction Technology-Should We Stay or Should We Go…? von Piccin, Andrea, Allameddine, Allameddine, Spizzo, Gilbert, Lappin, Katrina M, Prati, Daniele

    Veröffentlicht in Journal of clinical medicine

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Effect of Deferasirox Combined with Erythropoietin Versus Erythropoietin Alone on Erythroid Response in Patients with Low- and Int-1-Risk Myelodysplastic Syndromes: Results of the Phase II Kallisto Trial

    Effect of Deferasirox Combined with Erythropoietin Versus Erythropoietin Alone on Erythroid Response in Patients with Low- and Int-1-Risk Myelodysplastic Syndromes: Results of the... von Gattermann, Norbert, Coll, Rosa, Jacobasch, Lutz, Allameddine, Allameddine, DeBonnett, Laurie, Azmon, Amin, Jin, Jie

    Veröffentlicht in Blood

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial

    Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial von Gattermann, Norbert, Coll, Rosa, Jacobasch, Lutz, Allameddine, Allameddine, Azmon, Amin, DeBonnett, Laurie, Bruederle, Andreas, Jin, Jie

    Veröffentlicht in European journal of haematology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    47 Triple Negative Breast Cancer – Experience of a Single Tertiary Center

    47 Triple Negative Breast Cancer – Experience of a Single Tertiary Center von Allameddine, R, Shamseddine, A, Mukherji, D, Elias, E, Faraj, W, Hattoum, H, Saleh, A, El Saghir, N.S


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: